It was observed by He et al. that under combination with RES, the rapamycin-induced AKT phosphorylation was significantly decreased, and the antitumor activity of rapamycin in breast cancer cell lines was enhanced, suggesting that RES could assist rapamycin to increase the therapeutic efficacy (He et al., 2011). Here, AKT1 is linked to breast cancer.